Figure 1.
The skin lesions before and after abrocitinib therapy. (A) The skin lesions on the perioral region; (B) Two weeks after the abrocitinib therapy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.